On this episode, I chat with Jason Mellad, CEO of Start Codon, about the Biotech investment market and startup success.

Jason talked about the importance of strong, adaptable teams in early-stage companies and offers plenty of practical advice on understanding the market, recognising weaknesses, and trying to continuously improve. He shared the most common fundraising mistakes he sees, and the things that turn him off as an investor.

Jason is always great value, and the advice he gave in this interview was no exception. Come listen for the masterclass you might just need...

Pam Garside is an experienced angel investor and Chair of Cambridge Angels, one of the UK's leading investor networks.

On this epsiode of The Other Side of The Table, we sat down with Pam to discuss the importance of smart money, why tenacity, boldness and perserverance are critical traits for founders, and her top tips on your investment deck.

Enjoy!

We're back on The Other Side of the Table with Lee Lindley, Investment Manager at Mercia Ventures.

Lee and I got into a range of topics in this podcast, including the importance of engaging early with investors, thinking beyond your next round and why it's so critical for CEOs to get their team involved in fundraising conversations.

Join us for all this and a whole lot more!

Hanadi Jabado is the Managing Partner at Sana Capital, a fund with a brilliant mission - to heal the world.

Hanadi talked to us on The Other Side of The Table about the investment philosophy behind that mission, why algorithms aren't really what matters, the key role that trust plays in effective founder-investor relationships and why the market may not turn until early 2025.

Come join us for all this and more on the latest episode now!

Come join me and the ever-insightful Darrin Disley, founding CEO of Horizon Discovery, current Chief Exec of Mogrify and investor in more than 40 Life Sciences and Social Enterprise businesses.

In this episode, we got into why angel investors have different motivations, the importance of vision, why getting your cap structure right is absolutely critical, and much more.

I'm back on The Other Side of The Table with Sean Kendall, Partner at ARCH Venture Partners.

We're talking his view on the market (including my favourite quote of the series so far - "it's hard to fall out of the basement window"), why everything starts with high quality science, and how to tell if a market is "big enough" for investors.

This time around I'm with Mark Wyatt, Investment Director at Northern Gritstone, a group focused on realising the potential of innovation from universities across the North of England.

In this episode, you'll hear about the importance of purpose to investors, what the due diligence process is really about and why you shouldn't be afraid to show the weaknesses of your business, as well as its' strengths.

This time around on The Other Side of The Table, come with me to meet Uzma Choudry, Biotech/TechBio investment lead at Octopus Ventures.

Uzma built Octopus' TechBio desk and is an active investor and board member at several Biotech and TechBio companies - if you've spent any time on the UK Bio networking scene, you may well have come across her.

There aren't many people who know the space better, and Uzma's insights on how to leverage your existing investors when you pitch, why you should spend more time pursuing grant funding and the drivers of the current market are essential for anyone out raising money.

Come join us for this and a whole lot more!